IPOs - All articles

  • Henlius Biotech wins shareholder approval for Star dual listing

    Hong Kong-listed Shanghai Henlius Biotech got the go ahead from its controlling shareholders on Monday for a secondary flotation on China’s Star Market.

    • 31 Mar 2020
  • Sunkwan Properties plans Hong Kong IPO

    China-based Sunkwan Properties Group is looking to Hong Kong as a venue to go public, enlisting ABC International as the sponsor for the IPO.

    • 31 Mar 2020
  • Kangji Medical lines up Hong Kong listing

    Mainland-based Kangji Medical Holdings is seeking approval to list in Hong Kong. It has filed an IPO application with the city’s bourse.

    • 30 Mar 2020
  • Property developer Radiance Holdings targets HK listing

    Chinese property developer Radiance Holdings (Group) Co is getting ready to speak to potential investors for its Hong Kong IPO.

    • 26 Mar 2020
  • Ex-HKEX IPO executive, consultant face bribery charges

    A former joint head of the IPO vetting team in the Hong Kong Stock Exchange's listings department has been charged with bribery and misconduct while in office.

    • 25 Mar 2020
  • Redsun Services readies $100m Hong Kong IPO

    Chinese property management company Redsun Services Group is planning a Hong Kong listing that could raise up to $100m, according to a source familiar with the matter.

    • 24 Mar 2020
  • Esaf wins listing approval in choppy Indian markets

    India’s market regulator has approved Esaf Small Finance Bank to launch its IPO of about Rp9.8bn ($128.3m).

    • 24 Mar 2020
  • CSRC gives more clarity to Star board IPO hopefuls

    The China Securities Regulatory Commission (CSRC) has shed some light on the kinds of companies that are eligible to list on the Star board, solving part of a problem that has long puzzled potential IPO candidates.

    • 23 Mar 2020
  • InnoCare Pharma soars after online listing ceremony

    Chinese biotechnology company InnoCare Pharma’s shares surged over 10% on their Monday debut, following an online opening ceremony for the HK$2.2bn ($288.7m) listing in Hong Kong.

    • 23 Mar 2020
  • Acleda Bank fixes IPO price, extends bidding period

    Cambodia’s Acleda Bank has set the share price for its IPO after two roadshows events, but has extended the subscription period to accommodate the government’s coronavirus containment measures.

    • 23 Mar 2020
  • Cathay Media refiles for Hong Kong IPO

    China’s Cathay Media and Education Group has re-applied for approval to float in Hong Kong, submitting documents on Thursday with its latest financial figures.

    • 20 Mar 2020
  • Companies plot Star IPO comebacks

    Shanghai Titan Scientific, Speechocean and Easton Biopharmaceuticals are all planning to make a second attempt at listing on Shanghai’s Star market.

    • 18 Mar 2020
  • JD.com mandates for Hong Kong IPO

    Chinese e-commerce giant JD.com has hired Bank of America and UBS to lead a secondary listing in Hong Kong, according to multiple sources familiar with the matter.

    • 18 Mar 2020
  • InnoCare Pharma IPO a 'litmus test' for issuers

    Chinese biotechnology firm InnoCare Pharma has priced its HK$2.2bn ($288m) IPO at the top of the marketed range, following solid demand from institutional and retail investors, according to bankers close to the deal.

    • 17 Mar 2020
  • Chin up: ECM bankers hunt for business as markets tumble

    Asian equity indices were a sea of red on Monday, wiping out the gains from last Friday following the announcements of US and European stimulus packages. Primary market deal flow is almost non-existent, but bankers continue to pitch for business.

    • 16 Mar 2020
  • Indian IPOs delayed amid market mayhem

    A handful of Indian listings that had been expected by the end of March have been pushed back after a traumatic week for domestic and global markets.

    • 13 Mar 2020
  • InnoCare IPO tackles virus with virtual roadshow

    Global equity capital markets suffered severe hits this week, as governments scrambled to respond to an escalation in the coronavirus pandemic. But amid the mayhem, InnoCare Pharma saw an opportunity to launch its IPO, treating Hong Kong to its largest listing in about two months. Jonathan Breen reports.

    • 12 Mar 2020
  • SBI Cards set to allocate Rp103bn IPO

    SBI Cards and Payments Services has priced its Rp103.4bn ($1.4bn) IPO at the top of the range and was allocating the stock to investors on Wednesday.

    • 11 Mar 2020
  • InnoCare Pharma launches IPO with cornerstone backing

    Chinese biopharmaceutical firm InnoCare Pharma kicked off bookbuilding for its Hong Kong IPO on Wednesday, securing over half of the deal with cornerstone investors.

    • 11 Mar 2020
  • Asia’s IPO markets need to adapt quickly

    Asia’s IPO markets have been hit hard by the coronavirus epidemic, as travel bans and self-quarantine orders have delayed roadshows and brought deal flow to a near standstill. For the listing markets to survive, issuers, ECM bankers and investors need to adapt rapidly — and put some faith in technology.

    • 10 Mar 2020
  • India plans exit from oil giant BPCL

    The Indian government is looking to sell its entire majority stake in Bharat Petroleum Corp (BPCL) and has invited expressions of interest from strategic buyers.

    • 09 Mar 2020
  • Myanmar opens YSX to foreign investors

    The Yangon Stock Exchange will be open for trading by international investors from March 20, according to an announcement by Myanmar’s securities regulator.

    • 09 Mar 2020
  • Immunotech Biopharm seeks nod for HK IPO

    China’s Immunotech Biopharm has applied for listing approval in Hong Kong, aiming to raise more than $100m from its IPO, according to a source familiar with the matter.

    • 09 Mar 2020
  • Acleda Bank launches $94m IPO to break Cambodian ECM drought

    Acleda Bank has kicked off bookbuilding for a Riel380.7bn ($94.4m) IPO, set to be the first on the stock exchange in almost three years.

    • 06 Mar 2020
  • SBI Cards IPO sails through choppy Indian ECM markets

    SBI Cards and Payment Services was riding high on Thursday after a rush of institutional investor demand pushed its billion-dollar IPO through a coronavirus-driven slump in local and global markets this week. Jonathan Breen reports.

    • 05 Mar 2020
  • Robi Axiata bringing rare size to Bangladesh with $62m IPO

    Robi Axiata has submitted an application to the Bangladesh securities regulator for a Taka5.2bn ($62m) IPO, set to be the largest in nearly a decade.

    • 04 Mar 2020
  • Equitas Small Finance wins approval for Indian IPO

    India’s market regulator has given Equitas Small Finance Bank (ESF) the go-ahead for its IPO, which is expected to raise about Rp10bn ($136.3m).

    • 04 Mar 2020
  • Ever Flow River set for rare Myanmar IPO

    Logistics conglomerate Ever Flow River Group (EFR) has won approval from the Yangon Stock Exchange to join its sparsely populated board.

    • 03 Mar 2020
  • United Hampshire Reit thrives on 'safe haven' demand

    United Hampshire US Real Estate Investment Trust (Reit) has wrapped up the international roadshow for its $323.6m Singapore IPO, boosted by investors' search for stability amid volatile markets.

    • 03 Mar 2020
  • India's SBI Cards opens $1.4bn IPO with strong anchor backing

    SBI Cards and Payments Services has kicked off its up to Rp103.4bn ($1.4bn) IPO, with over one quarter of the deal subscribed by anchor investors.

    • 02 Mar 2020
  • InnoCare Pharma prepares $300m Hong Kong IPO

    Chinese biotechnology company InnoCare Pharma has won final approval for its Hong Kong IPO. The next step is marketing the deal, after delayed investor meetings in February.

    • 02 Mar 2020